0001752724-22-001421.txt : 20220112 0001752724-22-001421.hdr.sgml : 20220112 20220112122342 ACCESSION NUMBER: 0001752724-22-001421 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20211031 FILED AS OF DATE: 20220112 DATE AS OF CHANGE: 20220112 EFFECTIVENESS DATE: 20220112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SCHWAB INVESTMENTS CENTRAL INDEX KEY: 0000869365 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-06200 FILM NUMBER: 22526049 BUSINESS ADDRESS: STREET 1: 211 MAIN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 1-415-667-7000 MAIL ADDRESS: STREET 1: 211 MAIN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94105 0000869365 S000006807 Schwab 1000 Index Fund C000018433 Schwab 1000 Index Fund SNXFX N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0000869365 XXXXXXXX 811-06200 false false false N-1A S000006807 C000018433 SCHWAB INVESTMENTS 811-06200 0000869365 549300V41RCJNTEW5K68 211 MAIN STREET SAN FRANCISCO 94105 US-CA US 800-648-5300 Charles Schwab Investment Management, Inc. 211 Main Street San Francisco 94105 800-648-5300 Investment Manager and Fund Administrator Charles Schwab & Co., Inc. 211 Main Street San Francisco 94105 800-648-5300 Principal Underwriter BNY Mellon Investment Servicing, Inc. 4400 Computer Drive Westborough 01581 800-441-9800 Transfer Agent Schwab Investments Trust 211 Main Street San Francisco 94105 800-648-5300 Trust and Fund Records State Street Bank and Trust Company One Lincoln Street Boston 02111 617-786-3000 Custodian and Fund Accountant N N N-1A 8 Y Nancy F. Heller 001813276 N John F. Cogan N/A N Walter W. Bettinger II 002915574 Y David L. Mahoney N/A N Joseph R. Martinetto 002996277 Y Kimberly S. Patmore N/A N Jean Derek Penn 001310915 N Kiran M. Patel N/A N Jane P. Moncreiff N/A N Robert W. Burns N/A N Michael Hogan 002986381 One International Place Boston 02110 XXXXXX N N N N N N N Charles Schwab & Co., Inc. 8-16514 000005393 549300ZP8XN77GK5BS04 Y N Deloitte & Touche LLP 34 00000000000000000000 N N N N N N N Schwab 1000 Index Fund S000006807 549300POUDZNU374H849 N 1 0 0 Y N 0.00000000 -0.07000000 0.00000000 0.00000000 N N Y N N Goldman Sachs Bank USA KD3XUN7C6T14HNAYLU02 N N Revenue sharing split Cash collateral reinvestment fee 6703179.95000000 122453.16000000 Rule 32a-4 (17 CFR 270.32a-4) Rule 17a-7 (17 CFR 270.17a-7) N N N N Charles Schwab Investment Management, Inc. 801-35905 000106753 EVQ6EP3QESDF386W4D54 N BNY Mellon Investment Servicing (US) Inc. 084-01761 549300CFZQLI9QMJ1Z03 N N Y ICE Data Services, Inc. 13-3668779 Tax ID N Refinitiv US Holdings Inc. 549300NF240HXJO7N016 N N State Street Trust Company Canada 549300L71XG2CTQ2V827 CA N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) State Street Bank and Trust Company 571474TGEMMWANRLN572 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N BNY Mellon Investment Servicing (US) Inc. 549300CFZQLI9QMJ1Z03 N N Y Charles Schwab Investment Management, Inc. EVQ6EP3QESDF386W4D54 Y N N TD Ameritrade Clearing, Inc. 8-16335 000005633 MRK678VXOI09YSSN8X19 0.00000000 TD Ameritrade Singapore Pte. Ltd. N/A N/A 00000000000000000000 SG 0.00000000 TD Ameritrade, Inc. 8-23395 000007870 CWQYQU0TV2NLMLZKNB44 0.00000000 Charles Schwab, U.K., Limited N/A N/A 549300PF2KTM8A12FH91 GB 0.00000000 Charles Schwab & Co., Inc. 8-16514 000005393 549300ZP8XN77GK5BS04 0.00000000 TD Ameritrade Hong Kong Limited N/A N/A 00000000000000000000 HK 0.00000000 Charles Schwab, Hong Kong, Ltd. N/A N/A 00000000000000000000 HK 0.00000000 Cantor Fitzgerald & Co. 8-201 000000134 5493004J7H4GCPG6OB62 9594.65000000 Piper Sandler & Co. 8-15204 000000665 549300GRQCWQ3XGH0H10 5866.94000000 Goldman Sachs & Co. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 9272.53000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 7764.33000000 Instinet, LLC 8-23669 000007897 549300MGMN3RKMU8FT57 8659.74000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 21412.53000000 Citadel Securities Institutional LLC 8-69663 000281102 549300MLQ1S3715IUK04 8983.80000000 Wells Fargo Securities, LLC 8-65876 000126292 VYVVCKR63DVZZN70PB21 15625.70000000 Citigroup Global Markets Inc. 8-8177 000007059 MBNUM2BPBDO7JBLYG310 14430.57000000 Barclays Capital Inc. 8-41342 000019714 AC28XWWI3WIBK2824319 11853.51000000 147752.91000000 BofA Securities, Inc. 8-69787 000283942 549300HN4UKV1E2R3U73 4651635.79000000 Citigroup Global Markets Inc. 8-8177 000007059 MBNUM2BPBDO7JBLYG310 1072614.00000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 8045482.50000000 Goldman Sachs & Co. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 14667883.14000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 3467236.50000000 33148873.93000000 N 12455171121.43923076 Committed 850000000.00000000 N Uncommitted 400000000.00000000 N N N N true INTERNAL CONTROL RPT 2 NCEN_811-06200_83232930_1021.htm schwabinvestments0642.htm - Generated by SEC Publisher for SEC Filing

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Trustees of Schwab Investments and Shareholders of Schwab 1000® Index Fund:

 

In planning and performing our audits of the financial statements of Schwab 1000® Index Fund (the “Fund”), as of and for the year ended October 31, 2021, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion.

 

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A fund's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A fund's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the trust; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of a fund's assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Fund’s annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls for safeguarding securities, that we consider to be a material weakness, as defined above, as of October 31, 2021.

This report is intended solely for the information and use of management and Board of Trustees of Schwab Investments and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

/s/ Deloitte & Touche LLP

Denver, Colorado

December 16, 2021